Evgen Pharma results “were ahead” of Northland Capital expectations
Northland Capital partners view on Evgen Pharma LON:EVG: Evgen Pharma’s maiden Final Results for the year ended 31 March 2016 were ahead of our expectations. The company is prudently deploying